Related Experiment Videos
A search for congenital rubella in psychiatric day treatment, language and learning centres
Insights
Undiagnosed congenital rubella (CR) was investigated in children with developmental disorders. A novel serological method identified potential CR cases, highlighting the condition's underdiagnosis and impact on central nervous system (CNS) development.
Area of Science:
- Pediatric Neurology
- Immunology
- Developmental Pediatrics
Background:
- Congenital rubella (CR) can lead to significant neurodevelopmental deficits.
- Accurate diagnosis of CR is crucial for genetic counseling and prognosis.
Purpose of the Study:
- To identify previously undiagnosed cases of congenital rubella (CR) in children attending specialized treatment centers.
- To evaluate a novel serological approach for detecting CR in a pediatric population.
Main Methods:
- A cohort of 672 children with learning, speech, or psychiatric disorders was screened.
- Seronegative children were vaccinated against rubella, and their seroresponse was monitored.
- Failure to seroconvert post-vaccination indicated potential CR, particularly in seronegative individuals.
Main Results:
- Of 225 seronegative children, 23 failed to seroconvert after initial vaccination.
- Five children did not respond even after revaccination, exhibiting severe language and learning disabilities and CNS disorders.
- The study suggests current methods identify only about 20% of affected children, indicating significant underdiagnosis.
Conclusions:
- The study identified a subset of children with potential undiagnosed CR, linked to severe neurodevelopmental issues.
- A specific CR diagnosis aids in genetic counseling and offers a more optimistic prognosis.
- The findings underscore the importance of considering CR in children with unexplained developmental delays and CNS abnormalities.
Abstract:
A search for previously undiagnosed congenital rubella (CR) was made on 672 children who had attended psychiatric day treatment, learning, and speech and language centres. This was done by observing the seroresponse of seronegative children to rubella vaccine, since 90% of patients with known CR who are seronegative fail to seroconvert to the vaccine. Of the 225 seronegative children 23 did not seroconvert after a single vaccination. Five of these failed to respond on revaccination. These five children had a high frequency of severe language and learning disability as well as frequent diagnoses of major CNS disorders. It is likely that a far greater number of children in the population studied had CR, since our methods identify only about 20% of those affected. Clinically, a specific diagnosis of CR is helpful in facilitating genetic counselling and in allowing the clinician to offer a more hopeful prognosis.